1 / 31

Dyspepsia Impact On Primary Care

Overview. The scale of the problem in primary careThe cost of dyspepsiaPractice-based dyspepsia clinics. The Scale of the Problem. Dyspepsia prevalence 40% populationNational data shows 3-5% population present to their GP with symptomsConsultation rates of 355 per 10000 pt yrs at age 25-44 to

erica
Download Presentation

Dyspepsia Impact On Primary Care

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


    1. Dyspepsia Impact On Primary Care Dr Paul Pickering GP, Bridlington Prescribing Lead YW&C PCT

    2. Overview The scale of the problem in primary care The cost of dyspepsia Practice-based dyspepsia clinics

    3. The Scale of the Problem Dyspepsia prevalence 40% population National data shows 3-5% population present to their GP with symptoms Consultation rates of 355 per 10000 pt yrs at age 25-44 to 789 per 10000 pt yrs at age 75-84 Population surveys imply 10% seek assistance from their GP 1% population referred for endoscopy Discrepancy between national data and population surveys due to a combination of factors including pt recall and correct clinical coding of reasons for consultationDiscrepancy between national data and population surveys due to a combination of factors including pt recall and correct clinical coding of reasons for consultation

    4. GI Drug Spend NHS GI drug spend is 1.26 billion(71% increase in 2 years) Source IMS BPI December 2002 GI represents 16% NHS drug budget NHS GI drug spend is 1.26 billion(71% increase in 2 years) Source IMS BPI December 2002 GI represents 16% NHS drug budget

    5. Cost of Dyspepsia 1.2 billion/yr with a cost growth of 8-9% 19 million prescriptions for PPIs PPIs account for 34% of the volume but 83% of the NHS upper GI spend Alginates are 41% of the volume and 4% of the NHS upper GI spend 40% of PPIs are being prescribed to long term users Maintenance dose PPI represents the minority NHS GI prescribing spend: source IMS BPI Dec 02 Note numbers above relate to NHS budget add further130M on endoscopies(2000)NHS GI prescribing spend: source IMS BPI Dec 02 Note numbers above relate to NHS budget add further130M on endoscopies(2000)

    6. Cost of Dyspepsia Source IMS Health-MAT to Feb 2003 PPIs are 34% volume and 83% spend Alginates are 41% volume and 4% of spend Cost PPIs up 9.3% alginates down 1.1% Volume PPIs up 12.6% alginates down 0.7% Source IMS Health-MAT to Feb 2003Source IMS Health-MAT to Feb 2003 PPIs are 34% volume and 83% spend Alginates are 41% volume and 4% of spend Cost PPIs up 9.3% alginates down 1.1% Volume PPIs up 12.6% alginates down 0.7% Source IMS Health-MAT to Feb 2003

    7. Cost of Dyspepsia Recorded reasons for long term PPI use Oesophagitis(2) 17% Reflux 40% Non-specific dyspepsia 30% Peptic ulcer disease 3% Oesophageal ulcer/stricture 2% Non-GI problems 1% Ref: (1) BNF September 2003, (2) Hungin APS, Rubin GP et al, 1999: Martin RM, Lim AG, 1998: Bashford JH, Norwood J, 1998 Findings at endoscopy British Society of Gastroenterology revised April 2002: 30% normal/30% HH,gastritis,duodenitis/10-17% oesophagitis/10-15%DU/5-10%GU/2%oesophageal-gastric cancerRef: (1) BNF September 2003, (2) Hungin APS, Rubin GP et al, 1999: Martin RM, Lim AG, 1998: Bashford JH, Norwood J, 1998 Findings at endoscopy British Society of Gastroenterology revised April 2002: 30% normal/30% HH,gastritis,duodenitis/10-17% oesophagitis/10-15%DU/5-10%GU/2%oesophageal-gastric cancer

    8. Cost of Dyspepsia Findings at endoscopy Normal 30% Mild inflammation/HH 30% Oesophagitis 10-17% Malignancy 2-3% DU 10-15% GU 5-10% Stats from BS of Gastroenterology revised Apr 2002. NICE new document in discussion presently states 60% endoscopies are normal.Stats from BS of Gastroenterology revised Apr 2002. NICE new document in discussion presently states 60% endoscopies are normal.

    9. National GORD Data

More Related